Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Timothy Siegert, PhD
Clinical Phase 2 Proof-of-Concept Study Evaluating the Effect of ALX-001 on Biomarkers of Synapse Structure and Function.
A GuideStar-Rated Charity
© Copyright 2026. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).